These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 30468135)
1. Cognitive impairment in major depressive disorder. Pan Z; Park C; Brietzke E; Zuckerman H; Rong C; Mansur RB; Fus D; Subramaniapillai M; Lee Y; McIntyre RS CNS Spectr; 2019 Feb; 24(1):22-29. PubMed ID: 30468135 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological Treatment of Cognitive Symptoms in Major Depressive Disorder. Pan Z; Grovu RC; Cha DS; Carmona NE; Subramaniapillai M; Shekotikhina M; Rong C; Lee Y; McIntyre RS CNS Neurol Disord Drug Targets; 2017; 16(8):891-899. PubMed ID: 28933261 [TBL] [Abstract][Full Text] [Related]
3. Cognitive remission: a novel objective for the treatment of major depression? Bortolato B; Miskowiak KW; Köhler CA; Maes M; Fernandes BS; Berk M; Carvalho AF BMC Med; 2016 Jan; 14():9. PubMed ID: 26801406 [TBL] [Abstract][Full Text] [Related]
4. Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target. Goeldner C; Ballard TM; Knoflach F; Wichmann J; Gatti S; Umbricht D Neuropharmacology; 2013 Jan; 64():337-46. PubMed ID: 22992331 [TBL] [Abstract][Full Text] [Related]
5. Cognition in major depressive disorder: a 'Systemically Important Functional Index' (SIFI). McIntyre RS; Lee Y Curr Opin Psychiatry; 2016 Jan; 29(1):48-55. PubMed ID: 26575300 [TBL] [Abstract][Full Text] [Related]
6. The glycine site of NMDA receptors: A target for cognitive enhancement in psychiatric disorders. Peyrovian B; Rosenblat JD; Pan Z; Iacobucci M; Brietzke E; McIntyre RS Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():387-404. PubMed ID: 30738126 [TBL] [Abstract][Full Text] [Related]
7. Measuring cognitive function in MDD: emerging assessment tools. Russo M; Mahon K; Burdick KE Depress Anxiety; 2015 Apr; 32(4):262-9. PubMed ID: 25421437 [TBL] [Abstract][Full Text] [Related]
9. Cognitive deficits in bipolar disorders: Implications for emotion. Lima IMM; Peckham AD; Johnson SL Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773 [TBL] [Abstract][Full Text] [Related]
10. The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder. McIntyre RS; Xiao HX; Syeda K; Vinberg M; Carvalho AF; Mansur RB; Maruschak N; Cha DS CNS Drugs; 2015 Jul; 29(7):577-89. PubMed ID: 26290264 [TBL] [Abstract][Full Text] [Related]
11. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. McIntyre RS; Cha DS; Soczynska JK; Woldeyohannes HO; Gallaugher LA; Kudlow P; Alsuwaidan M; Baskaran A Depress Anxiety; 2013 Jun; 30(6):515-27. PubMed ID: 23468126 [TBL] [Abstract][Full Text] [Related]
12. The association of cognitive deficits with mental and physical Quality of Life in Major Depressive Disorder. Knight MJ; Lyrtzis E; Baune BT Compr Psychiatry; 2020 Feb; 97():152147. PubMed ID: 31838296 [TBL] [Abstract][Full Text] [Related]
13. Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review. Bortolato B; Carvalho AF; McIntyre RS CNS Neurol Disord Drug Targets; 2014; 13(10):1804-18. PubMed ID: 25470396 [TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder. Cha DS; Carmona NE; Subramaniapillai M; Mansur RB; Lee Y; Hon Lee J; Lee J; Rosenblat JD; Shekotikhina M; Park C; Rong C; Greer TL; Lam R; Baune BT; Harrison J; McIntyre RS J Affect Disord; 2017 Nov; 222():14-20. PubMed ID: 28667888 [TBL] [Abstract][Full Text] [Related]
15. Understanding and managing Cognition in the Depressed Patient. Papakostas GI; Culpepper L J Clin Psychiatry; 2015 Apr; 76(4):418-25. PubMed ID: 25919832 [TBL] [Abstract][Full Text] [Related]
16. What is the overlap between subjective and objective cognitive impairments in MDD? Fava M; Mahableshwarkar AR; Jacobson W; Zhong W; Keefe RS; Olsen CK; Jaeger J Ann Clin Psychiatry; 2018 Aug; 30(3):176-184. PubMed ID: 30028891 [TBL] [Abstract][Full Text] [Related]
17. Cognition as a target in major depression: new developments. Solé B; Jiménez E; Martinez-Aran A; Vieta E Eur Neuropsychopharmacol; 2015 Feb; 25(2):231-47. PubMed ID: 25640673 [TBL] [Abstract][Full Text] [Related]
18. Comparative study of cognitive impairment between medicated and medication-free patients with remitted major depression: class-specific influence by tricyclic antidepressants and newer antidepressants. Nagane A; Baba H; Nakano Y; Maeshima H; Hukatsu M; Ozawa K; Suzuki T; Arai H Psychiatry Res; 2014 Aug; 218(1-2):101-5. PubMed ID: 24768252 [TBL] [Abstract][Full Text] [Related]
19. Neurocognitive profile of outpatients with unipolar depressive disorders. Schwert C; Stohrer M; Aschenbrenner S; Weisbrod M; Schröder A J Clin Exp Neuropsychol; 2019 Nov; 41(9):913-924. PubMed ID: 31437083 [No Abstract] [Full Text] [Related]
20. The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Rosenblat JD; Kakar R; McIntyre RS Int J Neuropsychopharmacol; 2015 Jul; 19(2):. PubMed ID: 26209859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]